May 21, 2012 Dear Stockholder:Kensey Nash Corp • May 21st, 2012 • Surgical & medical instruments & apparatus
As we publicly announced on May 3, 2012, Kensey Nash Corporation (“Kensey Nash”) has entered into an Agreement and Plan of Merger, dated as of May 2, 2012 (the “Merger Agreement”), with Koninklijke DSM N.V. (“DSM”) and its indirect wholly-owned subsidiary, Biomedical Acquisition Corporation, which provides for the acquisition of Kensey Nash by DSM. We are pleased to now report to you that, pursuant to the Merger Agreement, Biomedical Acquisition Corporation has today commenced a tender offer to purchase all of the outstanding shares of Kensey Nash common stock, including the associated Series A Junior Preferred Stock Purchase Rights, for $38.50 per share of common stock in cash.
